198 related articles for article (PubMed ID: 30053448)
1. Dietary hydrogenated vegetable fat exacerbates the activation of kynurenine pathway caused by peripheral lipopolysaccharide immune challenge in aged mice.
de Gomes MG; Souza LC; Boeira SP; Goes AR; Del Fabbro L; Filho CB; Donato F; Puntel RL; Jesse CR
Chem Biol Interact; 2018 Sep; 293():28-37. PubMed ID: 30053448
[TBL] [Abstract][Full Text] [Related]
2. Fish oil ameliorates sickness behavior induced by lipopolysaccharide in aged mice through the modulation of kynurenine pathway.
de Gomes MG; Souza LC; Goes AR; Del Fabbro L; Filho CB; Donato F; Prigol M; Luchese C; Roman SS; Puntel RL; Boeira SP; Jesse CR
J Nutr Biochem; 2018 Aug; 58():37-48. PubMed ID: 29870875
[TBL] [Abstract][Full Text] [Related]
3. Involvement of kynurenine pathway in depressive-like behaviour induced by nandrolone decanoate in mice.
Cattelan Souza L; de Brito MLO; Jesse CR; Boeira SP; de Gomes MG; Goes ATR; Fabbro LD; Machado FR; Prigol M; Nogueira CW
Steroids; 2020 Dec; 164():108727. PubMed ID: 32891681
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
[TBL] [Abstract][Full Text] [Related]
5. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.
Parrott JM; Redus L; Santana-Coelho D; Morales J; Gao X; O'Connor JC
Transl Psychiatry; 2016 Oct; 6(10):e918. PubMed ID: 27754481
[TBL] [Abstract][Full Text] [Related]
7. Influence of lifelong dietary fats on the brain fatty acids and amphetamine-induced behavioral responses in adult rat.
Trevizol F; Roversi K; Dias VT; Roversi K; Pase CS; Barcelos RC; Benvegnu DM; Kuhn FT; Dolci GS; Ross DH; Veit JC; Piccolo J; Emanuelli T; Bürger ME
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():215-22. PubMed ID: 23791617
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge.
Parrott JM; Redus L; O'Connor JC
J Neuroinflammation; 2016 May; 13(1):124. PubMed ID: 27233247
[TBL] [Abstract][Full Text] [Related]
9. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
[TBL] [Abstract][Full Text] [Related]
11. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?
Connor TJ; Starr N; O'Sullivan JB; Harkin A
Neurosci Lett; 2008 Aug; 441(1):29-34. PubMed ID: 18584961
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome.
Dinel AL; André C; Aubert A; Ferreira G; Layé S; Castanon N
Psychoneuroendocrinology; 2014 Feb; 40():48-59. PubMed ID: 24485475
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β1-42 peptide in mice.
Souza LC; Jesse CR; Antunes MS; Ruff JR; de Oliveira Espinosa D; Gomes NS; Donato F; Giacomeli R; Boeira SP
Brain Behav Immun; 2016 Aug; 56():363-77. PubMed ID: 26965653
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR
J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539
[TBL] [Abstract][Full Text] [Related]
15. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.
Song P; Ramprasath T; Wang H; Zou MH
Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases.
Boros FA; Bohár Z; Vécsei L
Mutat Res Rev Mutat Res; 2018; 776():32-45. PubMed ID: 29807576
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat.
Wang J; Li X; He S; Hu L; Guo J; Huang X; Hu J; Qi Y; Chen B; Shang D; Wen Y
J Ethnopharmacol; 2018 Mar; 214():13-21. PubMed ID: 29217494
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.
Larkin PB; Sathyasaikumar KV; Notarangelo FM; Funakoshi H; Nakamura T; Schwarcz R; Muchowski PJ
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2345-2354. PubMed ID: 27392942
[TBL] [Abstract][Full Text] [Related]
19. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
Front Immunol; 2020; 11():31. PubMed ID: 32153556
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia.
Réus GZ; Becker IRT; Scaini G; Petronilho F; Oses JP; Kaddurah-Daouk R; Ceretta LB; Zugno AI; Dal-Pizzol F; Quevedo J; Barichello T
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():55-63. PubMed ID: 29030243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
